20-quarter listed-company comparison

FMCG Processing - Other Stocks in India

FMCG Processing - Other: Orkla India Ltd owns the largest revenue base; Mukka Proteins Ltd has the fastest current growth.

01 · the index people search for

Nifty FMCG Processing - Other Index — Constituents & Performance

All 2 listed Indian FMCG Processing - Other companies are named here, largest first — the same constituent set people search for as the Nifty FMCG Processing - Other index. Every figure on this page is equal-weighted across those companies, so one large constituent cannot set the reading. Each number carries its own as-of date.

Orkla India Ltd₹7.5K Cr
Mukka Proteins Ltd₹795 Cr

02 · sector relative strength, before individual stocks

Is FMCG Processing - Other outperforming NIFTY 500?

FMCG Processing - Other has underperformed NIFTY 500 by 16.5% over the last 52 weeks. Over 13 weeks the gap is a shortfall of 4.5%. 1 of 1 covered company currently beats NIFTY on Mansfield relative strength, so leadership inside the sector is broad. Mukka Proteins Ltd is the strongest against the sector itself at +12%.

-4.5%Sector vs NIFTY 500 · 13 weeks

-16.5%Sector vs NIFTY 500 · 52 weeks

1/1Stocks leading NIFTY 500

1/1Stocks leading sector

Sector metric: — as of latest available · unclassified · direction unavailable.

The central tension: the companies with the most scale are not necessarily the companies creating the most change.

Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.

Bottom line

FMCG Processing - Other has underperformed NIFTY 500 by 16.5% over 52 weeks and 4.5% over 13 weeks. 1 of 1 covered companies beat NIFTY on Mansfield relative strength, while 1 of 1 beat the sector itself. Orkla India Ltd leads with revenue of ₹2,571 crore, based on 2 of 2 comparable companies through Jun 2026.

Companies

complete canonical membership

Combined market value

₹8.3K Cr

Orkla India Ltd

Revenue growing

2/2

positive TTM year-on-year growth

Beating NIFTY 500

1/1

positive Mansfield relative strength

Comparing 2 of 2

03 · research priority, made explicit

Best FMCG Processing - Other Stocks in India (Aug 2026), Ranked by Data

4-Factor Sector Score

An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.

Growth & earnings · 35%Capital efficiency · 25%Valuation · 20%Relative strength · 20%

Mukka Proteins Ltd has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 77% evidence confidence.

How this score is built, and what the marks mean

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

Top 10 FMCG Processing - Other Stocks in India

Company	Score	Price stage	Growth & earnings/35	Capital efficiency/25	Valuation/20	Relative strength/20
1Mukka Proteins LtdMUKKA	65.8/100Favorable setup77% evidence	TURNING	27.2/35 Revenue 76.1% · PAT 68.2% · OPM change 2 pp 95% evidence	8.6/25 ROCE 11.6% · OPM 10% 95% evidence	10.0/20 P/E 11.5× · PEG — 0% evidence	20.0/20 RS sector 12% · RS bench 7.7% · 1Y -2.5%4 of 12 weeks ahead 100% evidence
Exact sum: 27.2 + 8.6 + 10 + 20 = 65.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Orkla India LtdORKLAINDIA	43.1/100Mixed-negative evidence70% evidence	ASLEEP	12.2/35 Revenue 5.9% · PAT 12.2% · OPM change -2 pp 100% evidence	13.1/25 ROCE 14.9% · OPM 17% 100% evidence	7.8/20 P/E 24.6× · PEG 2.19 50% evidence	10.0/20 RS sector — · RS bench — · 1Y —1 of 12 weeks ahead 0% evidence
Exact sum: 12.2 + 13.1 + 7.8 + 10 = 43.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

04 · what price has already done

Market action

Mukka Proteins Ltd has the strongest one-year price move in FMCG Processing - Other at -2.5%. It also leads on Mansfield relative strength against NIFTY at +7.7%. 1 of 1 covered company is above zero on that measure. Every line covers 313 weekly closes through 2026-08-14.

Price and relative strength

Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.

05 · the story behind the numbers

FMCG Processing - Other — the story behind the numbers

This is the written read behind the FMCG Processing - Other figures above — what is actually happening in the sector, in words, with the evidence each claim rests on. It is dated 17 Apr 2026, so the words are older than the numbers. 2 themes are live here.

The FMCG Processing - Other sector presents a mixed near-term picture but a compelling long-term thesis. While severe commodity deflation has temporarily suppressed value realization and caused a miss in volume guidance, the underlying operational leverage is highly resilient, as evidenced by the 17.7% EBITDA growth.

The FMCG Processing - Other sector, represented solely by Orkla India Ltd (ORKLAINDIA) in this week's analysis, is navigating a complex but ultimately IMPROVING demand environment. For Q3 FY26, ORKLAINDIA reported a modest revenue growth of 3.4% year-on-year, reaching INR 636 crores. However, the company missed its volume growth guidance.

How old this read is: STALE — this read comes from our FMCG Processing - Other sector brief dated 17 Apr 2026, about 4 months ago. The page says so rather than dressing it up, and a fresh sector dive replaces it the day it runs.

What is live in this sector right now

Live theme	Severity	Evidence on file
Deflation in spices, specifically a 50% drop in chili prices, is impacting value realization.Named for ORKLAINDIA	medium	“This unprecedented price movement of over 30% was led by chili, which reduced by 50%. This has impacted our value realization.” Passing on price benefits to remain competitive while focusing on volume growth.
The Red Sea crisis impacted US distribution and led to stock build-up.Named for ORKLAINDIA	low	“there's been a little bit -- and also the Red Sea crisis was there last year. So there was a lot of stock build-up.” Working to cut stock levels to normalized levels by Q1 FY27.

Sources: our FMCG Processing - Other sector brief, 17 Apr 2026 · company earnings-call transcripts.

06 · compare level, then change

Revenue Scale & Growth Durability

Orkla India Ltd has the highest Revenue among the 2 FMCG Processing - Other companies compared here, at ₹2,571 crore. Mukka Proteins Ltd is next at ₹1,770 crore. Mukka Proteins Ltd has the highest Revenue growth at 76.1%, so level and change sit with different companies. 2 of 2 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Orkla India Ltd is the scale leader at ₹2,571 crore, 45.3% ahead of Mukka Proteins Ltd. Mukka Proteins Ltd's growth is 76.1% from a ₹1,770 crore base, with 15 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.

LeaderOrkla India Ltd · ₹2,571 crore

Gap45.3% versus #2 · Mukka Proteins Ltd

Persistence5/5 recent comparable periods

Coverage2/2 companies · 24 observations

Investor read: Orkla India Ltd is the scale benchmark; Mukka Proteins Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.

This conclusion weakens if: Orkla India Ltd's growth falls below Mukka Proteins Ltd's for two consecutive comparable reports while operating margin also compresses.

Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.

Revenuelargest

1Orkla India Ltd ORKLAINDIA₹2.6K Cr

2Mukka Proteins Ltd MUKKA⚠ unverified₹1.8K Cr

Revenue growthfastest growers

1Mukka Proteins Ltd MUKKA⚠ unverified76%

2Orkla India Ltd ORKLAINDIA5.9%

Revenue · company comparison

2/2 level · 2/2 change

On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.

All-company data · latest reported quarter

In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.

Company	Revenue	Revenue growth	Reported
Orkla India Ltd ORKLAINDIA	₹659 Cr	10%	Jun 2026
Mukka Proteins Ltd MUKKA⚠ unverified	₹490 Cr	187%	Jun 2026

Full 20-quarter history · every available company

Revenue · reported quarter history

Mukka Proteins Ltd · MUKKA⚠ unverified

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022₹397 Cr

Mar 2023₹421 Cr

Jun 2023₹274 Cr

Sep 2023₹332 Cr

Dec 2023₹517 Cr

Mar 2024₹257 Cr

Jun 2024₹172 Cr

Sep 2024₹149 Cr

Dec 2024₹303 Cr

Mar 2025₹382 Cr

Jun 2025₹171 Cr

Sep 2025₹245 Cr

Dec 2025₹654 Cr

Mar 2026₹381 Cr

Jun 2026₹490 Cr

Orkla India Ltd · ORKLAINDIA

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 2023—

Mar 2024—

Jun 2024₹564 Cr

Sep 2024₹620 Cr

Dec 2024₹615 Cr

Mar 2025₹596 Cr

Jun 2025₹597 Cr

Sep 2025₹650 Cr

Dec 2025₹636 Cr

Mar 2026₹626 Cr

Jun 2026₹659 Cr

Revenue growth · reported quarter history

Mukka Proteins Ltd · MUKKA⚠ unverified

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 202330%

Mar 2024-39%

Jun 2024-37%

Sep 2024-55%

Dec 2024-41%

Mar 202549%

Jun 2025-0.6%

Sep 202564%

Dec 2025116%

Mar 2026-0.3%

Jun 2026187%

Orkla India Ltd · ORKLAINDIA

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 20255.9%

Sep 20254.8%

Dec 20253.4%

Mar 20265.0%

Jun 202610%

07 · compare level, then change

Operating Economics & Margin Trend

Orkla India Ltd has the highest OPM among the 2 FMCG Processing - Other companies compared here, at 17%. Mukka Proteins Ltd is next at 10%. Mukka Proteins Ltd has the highest Margin change at +2 percentage points, so level and change sit with different companies. 2 of 2 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Orkla India Ltd leads opm at 17%; Mukka Proteins Ltd leads margin change at +2 percentage points.

LeaderOrkla India Ltd · 17%

Gap70% versus #2 · Mukka Proteins Ltd

Persistence2/5 recent comparable periods

Coverage2/2 companies · 24 observations

Investor read: Orkla India Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current margin change signal.

Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.

OPMhighest

1Orkla India Ltd ORKLAINDIA17%

2Mukka Proteins Ltd MUKKA⚠ unverified10%

Margin changefastest expanders

1Mukka Proteins Ltd MUKKA⚠ unverified+2.0 pp

2Orkla India Ltd ORKLAINDIA−2.0 pp

Operating margin · company comparison

2/2 level · 2/2 change

All-company data · latest reported quarter

Company	OPM	Margin change	Reported
Orkla India Ltd ORKLAINDIA	17%	−2.0 pp	Jun 2026
Mukka Proteins Ltd MUKKA⚠ unverified	10%	+2.0 pp	Jun 2026

Full 20-quarter history · every available company

OPM · reported quarter history

Mukka Proteins Ltd · MUKKA⚠ unverified

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 20229.0%

Mar 202310%

Jun 20235.0%

Sep 202311%

Dec 20233.6%

Mar 202413%

Jun 20248.0%

Sep 20246.0%

Dec 202414%

Mar 20258.0%

Jun 20258.0%

Sep 20258.0%

Dec 20257.0%

Mar 20269.0%

Jun 202610%

Orkla India Ltd · ORKLAINDIA

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 2023—

Mar 2024—

Jun 202415%

Sep 202418%

Dec 202414%

Mar 202516%

Jun 202519%

Sep 202516%

Dec 202516%

Mar 202616%

Jun 202617%

Margin change · reported quarter history

Mukka Proteins Ltd · MUKKA⚠ unverified

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 2023−5.4 pp

Mar 2024+3.0 pp

Jun 2024+3.0 pp

Sep 2024−5.0 pp

Dec 2024+10.4 pp

Mar 2025−5.0 pp

Jun 20250.0 pp

Sep 2025+2.0 pp

Dec 2025−7.0 pp

Mar 2026+1.0 pp

Jun 2026+2.0 pp

Orkla India Ltd · ORKLAINDIA

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 2025+3.6 pp

Sep 2025−2.0 pp

Dec 2025+2.0 pp

Mar 20260.0 pp

Jun 2026−2.0 pp

08 · compare level, then change

Profit Scale & Acceleration

Orkla India Ltd has the highest Net profit among the 2 FMCG Processing - Other companies compared here, at ₹295 crore. Mukka Proteins Ltd is next at ₹74 crore. Mukka Proteins Ltd has the highest Profit growth at 68.2%, so level and change sit with different companies. 2 of 2 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Orkla India Ltd leads with ₹295 crore of TTM profit, 298.6% above Mukka Proteins Ltd. Mukka Proteins Ltd shows 68.2% growth from a ₹74 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.

LeaderOrkla India Ltd · ₹295 crore

Gap298.6% versus #2 · Mukka Proteins Ltd

Persistence3/5 recent comparable periods

Coverage2/2 companies · 24 observations

Investor read: Orkla India Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.

Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.

Net profitlargest

1Orkla India Ltd ORKLAINDIA₹295 Cr

2Mukka Proteins Ltd MUKKA⚠ unverified₹74 Cr

Profit growthfastest growers

1Mukka Proteins Ltd MUKKA⚠ unverified68%

2Orkla India Ltd ORKLAINDIA12%

Net profit · company comparison

2/2 level · 2/2 change

All-company data · latest reported quarter

Company	Net profit	Profit growth	Reported
Orkla India Ltd ORKLAINDIA	₹88 Cr	11%	Jun 2026
Mukka Proteins Ltd MUKKA⚠ unverified	₹19 Cr	850%	Jun 2026

Full 20-quarter history · every available company

Net profit · reported quarter history

Mukka Proteins Ltd · MUKKA⚠ unverified

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022₹27 Cr

Mar 2023₹22 Cr

Jun 2023₹4 Cr

Sep 2023₹29 Cr

Dec 2023₹12 Cr

Mar 2024₹29 Cr

Jun 2024₹5 Cr

Sep 2024₹1 Cr

Dec 2024₹27 Cr

Mar 2025₹14 Cr

Jun 2025₹2 Cr

Sep 2025₹7 Cr

Dec 2025₹27 Cr

Mar 2026₹21 Cr

Jun 2026₹19 Cr

Orkla India Ltd · ORKLAINDIA

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 2023—

Mar 2024—

Jun 2024₹72 Cr

Sep 2024₹83 Cr

Dec 2024₹66 Cr

Mar 2025₹35 Cr

Jun 2025₹79 Cr

Sep 2025₹77 Cr

Dec 2025₹57 Cr

Mar 2026₹73 Cr

Jun 2026₹88 Cr

Profit growth · reported quarter history

Mukka Proteins Ltd · MUKKA⚠ unverified

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 2023-56%

Mar 202432%

Jun 202425%

Sep 2024-97%

Dec 2024125%

Mar 2025-52%

Jun 2025-60%

Sep 2025600%

Dec 20250.0%

Mar 202650%

Jun 2026850%

Orkla India Ltd · ORKLAINDIA

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 20259.7%

Sep 2025-7.2%

Dec 2025-14%

Mar 2026109%

Jun 202611%

09 · compare level, then change

Return On Capital Employed

Orkla India Ltd has the highest ROCE among the 2 FMCG Processing - Other companies compared here, at 14.9%. Mukka Proteins Ltd is next at 11.6%. The same company also holds the highest ROCE change, at -0.3 percentage points. 2 of 2 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Orkla India Ltd leads ROCE at 14.9%, 3.3 percentage points above Mukka Proteins Ltd. Orkla India Ltd has the strongest latest improvement at -0.3 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.

LeaderOrkla India Ltd · 14.9%

Gap28.4% versus #2 · Mukka Proteins Ltd

Persistence0/1 recent comparable periods

Coverage2/2 companies · 22 observations

Investor read: Orkla India Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.

This conclusion weakens if: The next two comparable reports reverse the current roce change signal.

ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.

ROCEhighest

1Orkla India Ltd ORKLAINDIA15%

2Mukka Proteins Ltd MUKKA⚠ unverified12%

ROCE changefastest improvers

1Orkla India Ltd ORKLAINDIA−0.3 pp

2Mukka Proteins Ltd MUKKA⚠ unverified−0.6 pp

Return on capital · company comparison

2/2 level · 2/2 change

All-company data · latest reported quarter

Company	ROCE	ROCE change	Reported
Mukka Proteins Ltd MUKKA⚠ unverified	17%	−0.6 pp	Jun 2026
Orkla India Ltd ORKLAINDIA	13%	−0.3 pp	Jun 2026

Full 20-quarter history · every available company

ROCE · reported quarter history

Mukka Proteins Ltd · MUKKA⚠ unverified

Mar 2021—

Jun 20217.1%

Sep 202114%

Dec 202124%

Mar 202236%

Dec 202245%

Mar 202357%

Jun 2023—

Sep 202358%

Dec 202367%

Mar 202423%

Jun 202438%

Sep 202415%

Dec 202433%

Mar 202518%

Jun 202522%

Sep 202519%

Dec 202525%

Mar 202617%

Jun 2026—

Orkla India Ltd · ORKLAINDIA

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 202513%

Jun 202513%

Sep 202512%

Dec 202513%

Mar 202613%

Jun 2026—

ROCE change · reported quarter history

Mukka Proteins Ltd · MUKKA⚠ unverified

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022+38.2 pp

Mar 2023+42.7 pp

Jun 2023—

Sep 2023+21.1 pp

Dec 2023+21.2 pp

Mar 2024−34.1 pp

Jun 2024—

Sep 2024−42.4 pp

Dec 2024−34.0 pp

Mar 2025−5.1 pp

Jun 2025−15.9 pp

Sep 2025+4.3 pp

Dec 2025−7.1 pp

Mar 2026−0.6 pp

Jun 2026—

Orkla India Ltd · ORKLAINDIA

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 2025—

Sep 2025—

Dec 2025—

Mar 2026−0.3 pp

Jun 2026—

10 · compare level, then change

Valuation Against Growth & Quality

Orkla India Ltd has the lowest PEG among the 2 FMCG Processing - Other companies compared here, at 2.19×. Mukka Proteins Ltd has the lowest P/E at 11.5×, so level and change sit with different companies. 1 of 2 companies report a comparable reading, the latest through Jun 2026.

What the numbers say: Orkla India Ltd has the lowest comparable PEG at 2.19×. Only 1 of 2 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.

LeaderOrkla India Ltd · 2.19×

GapNot enough peers

Persistence0/3 recent comparable periods

Coverage1/2 companies · 0 observations

Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.

This conclusion weakens if: The next two comparable reports reverse the current p/e signal.

PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is recomputed consistently as the trailing P/E divided by that growth rate — reported earnings, never an expected-earnings multiple. On Indian companies it is shown only where the two data feeds agreed. Where any of that fails the ratio is left out rather than printed: a P/E divided by a loss, or by growth measured off a tiny base, is a number that looks precise and means nothing.

PEGlowest PEG

1Orkla India Ltd ORKLAINDIA2.2

P/Elowest P/E

1Mukka Proteins Ltd MUKKA⚠ unverified11.5

2Orkla India Ltd ORKLAINDIA24.6

Valuation · company comparison

1/2 level · 2/2 change

All-company data · latest reported quarter

Company	PEG	P/E	Reported
Orkla India Ltd ORKLAINDIA	2.2	3.3	Jun 2026
Mukka Proteins Ltd MUKKA⚠ unverified	—	14.0	Jun 2026

Full 20-quarter history · every available company

No consistent historical series is available for peg.

P/E · reported quarter history

Mukka Proteins Ltd · MUKKA⚠ unverified

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 2023—

Mar 202412.5

Jun 202412.5

Sep 202414.9

Dec 202424.4

Mar 202516.4

Jun 202519.5

Sep 202518.2

Dec 202515.2

Mar 202613.3

Jun 202614.0

Orkla India Ltd · ORKLAINDIA

Mar 2021—

Jun 2021—

Sep 2021—

Dec 2021—

Mar 2022—

Dec 2022—

Mar 2023—

Jun 2023—

Sep 2023—

Dec 2023—

Mar 2024—

Jun 2024—

Sep 2024—

Dec 2024—

Mar 2025—

Jun 2025—

Sep 2025—

Dec 20253.4

Mar 20263.1

Jun 20263.3

11 · before the conclusion, check the blind spots

What can make this comparison misleading?

This FMCG Processing - Other comparison names 6 specific ways its own evidence can mislead, all listed below. All 2 companies here report on comparable dates, so no rank carries a stale marker. 1 draws at least one figure from a second feed with too little overlap to cross-check. A high growth rate can still be a low-base artefact.

Keep these limits visible

A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
1 company draws at least one figure from a second data feed with too little overlapping history to cross-check against the primary source; it is marked unverified wherever that figure appears.
Thin comparisons: Valuation have fewer than three usable current readings.

12 · evidence and freshness

How was this comparison built?

This comparison is built from the reported filings of 2 FMCG Processing - Other companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-08-14. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.

FundamentalsThrough Jun 2026 · up to 20 quarters per company

Market dataThrough 2026-08-14 · weekly price and relative-strength history

Derived metricsGrowth, changes and PEG are calculated only when their inputs are comparable.

Score confidenceMissing and stale evidence reduces confidence and pulls the 0–100 research-priority score toward neutral.

Source standing1 cross-checked · 1 unverified · 0 withheld, of 2 graded companies.

How a second data feed is admitted, and what happens when it disagrees

A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.

13 · questions investors ask, short speakable answers

FMCG Processing - Other company comparison FAQs

These 23 answers restate the FMCG Processing - Other comparison above in question form. Every one is computed from the same 2 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-08-14. Nothing here is estimated, and none of it is a recommendation.

Is the FMCG Processing - Other sector outperforming NIFTY 500?

Which FMCG Processing - Other company is largest by revenue?

Orkla India Ltd leads with revenue of ₹2,571 crore, based on 2 of 2 comparable companies through Jun 2026.

Which FMCG Processing - Other company is growing fastest?

Mukka Proteins Ltd has the fastest current revenue growth at 76.1%, across 2 of 2 comparable companies.

Which FMCG Processing - Other company has the strongest 4-Factor Sector Score?

Mukka Proteins Ltd ranks first at 65.8/100 with 77% evidence confidence. The score prioritizes research; it is not a buy recommendation.

Which FMCG Processing - Other company has the lowest comparable PEG?

Orkla India Ltd has the lowest comparable PEG at 2.19, among 1 of 2 companies whose earnings and growth are steady enough for the ratio to mean anything.

How much history does this FMCG Processing - Other comparison include?

The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.

How is the 4-Factor Sector Score calculated?

The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.

Is there a Nifty FMCG Processing - Other index?

NSE India maintains Nifty indices for several broad sector categories — Nifty Bank, Nifty IT, Nifty Pharma and others — but not for every sub-sector grouping on this site. Whether or not an official Nifty index covers FMCG Processing - Other, this page builds its own equal-weight basket of 2 listed FMCG Processing - Other companies — one company, one vote, regardless of market value — so no single large company dominates the reading. Figures are as of Jun 2026.

Which are the best FMCG Processing - Other stocks in India?

Ranked by this page's four-factor score, Mukka Proteins Ltd places first among 2 listed FMCG Processing - Other companies, followed by Orkla India Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.

How many FMCG Processing - Other stocks are listed in India?

This comparison covers 2 listed FMCG Processing - Other companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.

Which FMCG Processing - Other company is the biggest?

Orkla India Ltd is the largest, with trailing-twelve-month revenue of ₹2,571 crore, ahead of Mukka Proteins Ltd at ₹1,770 crore. That covers 2 of 2 companies with comparable reporting through Jun 2026.

Which FMCG Processing - Other company has the best profit margins?

Orkla India Ltd has the highest operating margin at 17%, from 2 of 2 comparable companies. Mukka Proteins Ltd shows the biggest recent improvement, at +2 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.

Which FMCG Processing - Other company makes the most profit?

Orkla India Ltd earns the most, at ₹295 crore of trailing-twelve-month net profit, from 2 of 2 comparable companies. Mukka Proteins Ltd has the fastest profit growth at 68.2%, though growth off a small or recovering profit base overstates how much has actually changed.

Which FMCG Processing - Other company earns the highest return on capital?

Orkla India Ltd leads on return on capital employed at 14.9%, across 2 of 2 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.

Which FMCG Processing - Other stock is the cheapest?

On PEG — where a LOWER number is cheaper — Orkla India Ltd screens cheapest at 2.19×. Only 1 of 2 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.

Is the FMCG Processing - Other sector beating the market?

FMCG Processing - Other has underperformed NIFTY 500 by 16.5% over the last 52 weeks and 4.5% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 1 of 1 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.

Which FMCG Processing - Other stock has the strongest price momentum?

Mukka Proteins Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.

Which FMCG Processing - Other company scores highest for research priority?

Mukka Proteins Ltd scores 65.8 out of 100 with 77% evidence confidence, from 27.2 points on growth and earnings, 8.6 on capital efficiency, 10 on valuation and 20 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.

How many FMCG Processing - Other companies does this comparison cover, and over what period?

It compares 2 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.

What is the total market cap of the FMCG Processing - Other sector?

The 2 FMCG Processing - Other companies on this page carry ₹8,326 crore of combined market value. Orkla India Ltd is the largest at ₹7,531 crore, about 90% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-08-20.

How is the FMCG Processing - Other sector performing?

1 of the 1 covered FMCG Processing - Other companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 16.5% behind NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-08-20.

Why are some values on this page blank?

A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.

Is this investment advice?

No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.